CRIO Joins Forces with the Association of Diversity in Clinical Trials as a Supporting Partner to Drive Inclusive Research Advancements
Tuesday, August 22, 2023
DALLAS, Aug. 14, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD) and CRIO, a leading eSource technology provider, are excited to announce a new partnership. CRIO's software platform empowers research sites to run more effectively, enabling research in underserved communities. CRIO's work aligns with AOD's mission to establish standards and best practices for the clinical trials industry to improve the representation of diverse participants in clinical trials through the development, integration, and monitoring of quality and consistent diversity methodology across the research industry.
By joining the AOD as a Supporting partner, CRIO and CEO Raymond Nomizu, continue their commitment to being an ally in the improvement of Diversity in clinical trials. "CRIO enables the start-up of new sites and investigators, enabling research in previously underserved communities, "says Raymond Nomizu, CEO at CRIO. "CRIO supports the mission of Association of Diversity and looks forward to collaborating with other industry stakeholders to advance the mission."
Dr. Diana Foster, AOD's CEO, highlighted the vital role of technology and CRIO in advancing their mission. Dr. Foster explains "Technology-driven methods cut costs, expedite trials, and aid personalized treatments, ultimately accelerating safer therapies to patients. CRIO's innovation in the technology sector remains evident." The AOD's collaborative efforts aim to reshape clinical trial diversity in the industry.
About The Association of Diversity in Clinical Trials The AOD is comprised of partners who are committed to developing evidence-based approaches including, consultive advisement, consolidation of the understanding of diversity challenges: report, and the development of standards for best practices at the site and sponsor level. For information about The Association of Diversity in Clinical Trials and to view the partnership levels, visit our website at www.associationofdiversity.org.
About CRIO CRIO is a health tech company helping pharma, biotech, research sites, and academic research centers streamline regulatory workflows with one system that enables a single point of data capture. As the leader in eSource technology, CRIO enables remote monitoring and immediate data review with a powerfully integrated eSource/EDC solution. CRIO's mission is to design and deliver a modern, intuitive, and integrated software platform that reimagines clinical trials for quality, speed, and patient-centricity.
http://www.clinicalresearch.io
Media Contact: Jeremy Mitchell, MBA Director, Business Development The Association of Diversity in Clinical Trials jmitchell@associationofdiversity.org 1-989-780-4244
View original content to download multimedia:https://www.prnewswire.com/news-releases/crio-joins-forces-with-the-association-of-diversity-in-clinical-trials-as-a-supporting-partner-to-drive-inclusive-research-advancements-301898513.html
SOURCE The Association of Diversity in Clinical Trials
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
 |
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
 |
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
 |
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
 |
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
 |
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
 |
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
 |
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
 |
AMPLIFY Named Finalist in Three Categories at the 2026 Golden Gavel Awards | Jan 22, 2026
|
 |
Gemmy Alerts Customers: Fake Websites Target Holiday Decorators | Jan 22, 2026
|
|
|